Lipella Pharmaceuticals Inc.
LIPO
$0.593
-$0.0002-0.03%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 134.45% | 100.68% | -33.66% | -43.83% | -61.89% |
| Total Receivables | 18.98% | 24.24% | 162.23% | -41.43% | 26.07% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -28.59% | -38.74% | 236.59% | 234.07% | 281.27% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 65.19% | 60.18% | -23.68% | -22.13% | -38.20% |
|
|
|||||
| Total Current Assets | 65.19% | 60.18% | -23.68% | -22.13% | -38.20% |
| Net Property, Plant & Equipment | 173.96% | -74.07% | -61.73% | -52.85% | -15.67% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 70.33% | 54.79% | -25.25% | -23.96% | -37.41% |
|
|
|||||
| Total Accounts Payable | 240.86% | 33.46% | 181.30% | 51.60% | 707.24% |
| Total Accrued Expenses | -53.96% | 116.90% | 101.52% | 7.89% | -3.56% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -54.22% | -73.83% | -46.64% | -18.90% | 54.11% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 55.51% | 40.75% | 95.74% | 27.79% | 60.74% |
|
|
|||||
| Total Current Liabilities | 55.51% | 40.75% | 95.74% | 27.79% | 60.74% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 103.73% | 34.88% | 74.35% | 13.24% | 31.88% |
|
|
|||||
| Common Stock & APIC | 46.32% | 47.23% | 28.15% | 29.53% | 23.79% |
| Retained Earnings | -44.33% | -44.56% | -48.59% | -44.25% | -49.84% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 60.92% | 59.26% | -38.96% | -34.33% | -45.48% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 60.92% | 59.26% | -38.96% | -34.33% | -45.48% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 60.92% | 59.26% | -38.95% | -34.33% | -45.48% |
|
|
|||||